Microfluidic Chip 3D Channel Structure for Cell Culture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current drug development processes, particularly for anticancer medicines, are lengthy and costly due to the inability of two-dimensional cell culture methods to accurately reflect the three-dimensional environment of multicellular tumor spheroids, leading to discrepancies in drug efficacy and toxicity assessment between cellular and animal testing.
Innovation Solution
A microfluidic chip with a three-dimensional channel structure and method for culturing cells, allowing for the formation of three-dimensional cell spheroids and evaluation of bioactive substances, mimicking the body's environment by using a bridge channel, inlets, outlets, and wells to simulate the interaction of cancer cells with vascular tissues and extracellular matrices.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If two-dimensional cell culture method is used, then ease of operation is improved, but measurement precision of drug efficacy is worsened
Solution Approach 1:
The patent transitions from two-dimensional cell culture to three-dimensional cell spheroid culture within a microfluidic chip. The channel structure with controlled cross-sections enables cells to self-assemble into spheroids that replicate in vivo tissue architecture, thereby improving measurement precision of drug efficacy while maintaining operational feasibility through standardized chip design
2Measurement precision
If multicellular tumor spheroids are used, then measurement precision of drug efficacy is improved, but device complexity is worsened
Solution Approach 1:
The microfluidic chip is divided into multiple independent channel structures, each with controlled cross-sectional areas. This segmentation allows cells to form spheroids of specific sizes in different channels, enabling precise control over spheroid morphology and size while maintaining a modular device architecture that manages complexity
Solution Approach 2:
The patent varies the cross-sectional area parameters of different channels to control spheroid formation. By adjusting geometric parameters of the channel structure rather than complex operational parameters, the device achieves precise control over cell spheroid characteristics while keeping the device structure relatively simple and manufacturable
3Ease of operation
If drug delivery by diffusion is used, then ease of operation is improved, but productivity of drug evaluation is worsened
Solution Approach 1:
The patent introduces fluid flow through the microfluidic channels to enhance drug delivery beyond passive diffusion. By controlling fluid dynamics in the channels, the system achieves more efficient and rapid drug transport to cell spheroids, significantly improving the productivity of drug evaluation while maintaining ease of operation through pump-controlled fluid delivery
Data Source
AI summary
The microfluidic chip according to an embodiment of the present invention may include a plate, a bridge channel formed in intaglio on one side of the plate, an inlet formed through the plate to communicate with one end of the bridge channel, an outlet formed through the plate to communicate with the other end of the bridge channel, and at least one well extending in an outward direction of the plate from the bridge channel to provide a space, wherein the bridge channel may be in the form of a curved line, a bent line, an arc, a circle, a spiral, or a polygon.